Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

SELL
$175.6 - $291.43 $44.7 Million - $74.2 Million
-254,470 Closed
0 $0
Q4 2020

Jan 14, 2021

SELL
$174.98 - $272.83 $3.6 Million - $5.62 Million
-20,600 Reduced 7.49%
254,470 $44.5 Million
Q3 2020

Nov 05, 2020

SELL
$185.27 - $238.73 $518,756 - $668,444
-2,800 Reduced 1.01%
275,070 $53.5 Million
Q2 2020

Jul 28, 2020

SELL
$153.32 - $191.72 $1.98 Million - $2.48 Million
-12,930 Reduced 4.45%
277,870 $49.7 Million
Q1 2020

Apr 28, 2020

BUY
$124.34 - $193.76 $2.25 Million - $3.51 Million
18,100 Added 6.64%
290,800 $46.9 Million
Q4 2019

Feb 05, 2020

BUY
$134.81 - $177.8 $4.04 Million - $5.33 Million
30,000 Added 12.36%
272,700 $44.8 Million
Q3 2019

Oct 25, 2019

BUY
$131.82 - $183.4 $2.25 Million - $3.14 Million
17,100 Added 7.58%
242,700 $32.6 Million
Q2 2019

Aug 01, 2019

BUY
$124.65 - $167.39 $28.1 Million - $37.8 Million
225,600 New
225,600 $36.1 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Ardevora Asset Management LLP Portfolio

Follow Ardevora Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ardevora Asset Management LLP with notifications on news.